Updates

CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices

Oct 25, 2018

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies Read More

SECOND OPINION: Don’t Be Fooled.  Drug Companies Are Responsible For High Drug Prices

Oct 23, 2018

Repeating the same false claim over and over again doesn’t make it true.  Read More

CSRxP Statement On HHS DTC Advertising Announcement

Oct 15, 2018

CSRxP issued the following statement in response to the U.S. Department of Read More

CSRxP Statement On PhRMA’s DTC Advertising Announcement

Oct 15, 2018

The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement Read More

ICYMI: CSRxP Calls On FDA To Break Down Barriers To Affordable Drugs

Oct 2, 2018

Through the advancement of modern medicine, biologic drugs are providing new Read More

Congress Rejects Big Pharma Bailout

Sep 26, 2018

Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers & Read More

Second Opinion: The Truth About The Big Pharma Bailout

Sep 25, 2018

In their latest attempt to make billions of dollars on the backs of patients, Read More

CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout

Sep 25, 2018

Washington, D.C. – Today the Campaign for Sustainable Rx Pricing Read More

Stop Big Pharma’s $4 Billion Bailout

Sep 21, 2018

As the country is hoping for lower drug prices, more affordable care Read More

CSRxP Statement on Potential Big Pharma Bailout

Sep 21, 2018

“Only Big Pharma would use bipartisan opioid legislation as another Read More

CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill

Sep 13, 2018

House Misses Bipartisan Opportunity To Hold Big Pharma Accountable Read More

SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices

Sep 12, 2018

Apparently, when it comes to out-of-control drug prices, everyone’s to blame Read More